170 related articles for article (PubMed ID: 33782009)
1. Efficacy and Associated Drug Exposures of Isavuconazole and Fluconazole in an Experimental Model of Coccidioidomycosis.
Kovanda LL; Sass G; Martinez M; Clemons KV; Nazik H; Kitt TM; Wiederhold N; Hope WW; Stevens DA
Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33782009
[No Abstract] [Full Text] [Related]
2. The Novel Fungal Cyp51 Inhibitor VT-1598 Is Efficacious in Experimental Models of Central Nervous System Coccidioidomycosis Caused by Coccidioides posadasii and Coccidioides immitis.
Wiederhold NP; Shubitz LF; Najvar LK; Jaramillo R; Olivo M; Catano G; Trinh HT; Yates CM; Schotzinger RJ; Garvey EP; Patterson TF
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437615
[TBL] [Abstract][Full Text] [Related]
3. The Orotomide Olorofim Is Efficacious in an Experimental Model of Central Nervous System Coccidioidomycosis.
Wiederhold NP; Najvar LK; Jaramillo R; Olivo M; Birch M; Law D; Rex JH; Catano G; Patterson TF
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29941638
[TBL] [Abstract][Full Text] [Related]
4. APX001 and Other Gwt1 Inhibitor Prodrugs Are Effective in Experimental
Viriyakosol S; Kapoor M; Okamoto S; Covel J; Soltow QA; Trzoss M; Shaw KJ; Fierer J
Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30455238
[TBL] [Abstract][Full Text] [Related]
5. Comparison of fluconazole and SDZ89-485 for therapy of experimental murine coccidioidomycosis.
Fierer J; Kirkland T; Finley F
Antimicrob Agents Chemother; 1990 Jan; 34(1):13-6. PubMed ID: 2327748
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of SCH39304 and fluconazole in a murine model of disseminated coccidioidomycosis.
Clemons KV; Hanson LH; Perlman AM; Stevens DA
Antimicrob Agents Chemother; 1990 May; 34(5):928-30. PubMed ID: 2360832
[TBL] [Abstract][Full Text] [Related]
7. [A case of coccidioidomycosis in Turkey imported from the United States of America].
Başaran S; Karabıçak N; Şimşek Yavuz S; Wiederhold NP; Şafak S; Sarıbuğa A; Sutton DA; Bingöl Z; Çağatay A; Özsüt H; Kılıçaslan Z; Eraksoy H
Mikrobiyol Bul; 2017 Apr; 51(2):183-190. PubMed ID: 28566083
[TBL] [Abstract][Full Text] [Related]
8. Utility of the triazole D0870 in the treatment of experimental systemic coccidioidomycosis.
Clemons KV; Stevens DA
J Med Vet Mycol; 1994; 32(4):323-6. PubMed ID: 7983578
[TBL] [Abstract][Full Text] [Related]
9. Isavuconazole in the Treatment of Chronic Forms of Coccidioidomycosis.
Heidari A; Sharma R; Shakir Q; Shah M; Clement J; Donnelley MA; Reynolds T; Trigg K; Jolliff J; Kuran R; Johnson R; Thompson GR
Clin Infect Dis; 2023 Jun; 76(12):2196-2199. PubMed ID: 36905151
[TBL] [Abstract][Full Text] [Related]
10. Activity of the triazole SCH 56592 against disseminated murine coccidioidomycosis.
Lutz JE; Clemons KV; Aristizabal BH; Stevens DA
Antimicrob Agents Chemother; 1997 Jul; 41(7):1558-61. PubMed ID: 9210684
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of isavuconazole, voriconazole and fluconazole in temporarily neutropenic murine models of disseminated Candida tropicalis and Candida krusei.
Majithiya J; Sharp A; Parmar A; Denning DW; Warn PA
J Antimicrob Chemother; 2009 Jan; 63(1):161-6. PubMed ID: 19008255
[TBL] [Abstract][Full Text] [Related]
12. Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses.
Thompson GR; Rendon A; Ribeiro Dos Santos R; Queiroz-Telles F; Ostrosky-Zeichner L; Azie N; Maher R; Lee M; Kovanda L; Engelhardt M; Vazquez JA; Cornely OA; Perfect JR
Clin Infect Dis; 2016 Aug; 63(3):356-62. PubMed ID: 27169478
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamics of Isavuconazole in a Rabbit Model of Cryptococcal Meningoencephalitis.
Kovanda LL; Giamberardino C; McEntee L; Toffaletti DL; Franke KS; Bartuska A; Smilnak G; de Castro GC; Ripple K; Hope WW; Perfect JR
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31209006
[No Abstract] [Full Text] [Related]
14. Isavuconazole as Salvage Therapy for Refractory Pediatric Coccidioidal Meningitis.
Naeem F; Laningham F; Kuzmic B; Clerkin P; McCarty J
Pediatr Infect Dis J; 2021 Mar; 40(3):e128-e131. PubMed ID: 33315746
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of VT-1161 for Treatment of Coccidioidomycosis in Murine Infection Models.
Shubitz LF; Trinh HT; Galgiani JN; Lewis ML; Fothergill AW; Wiederhold NP; Barker BM; Lewis ER; Doyle AL; Hoekstra WJ; Schotzinger RJ; Garvey EP
Antimicrob Agents Chemother; 2015 Dec; 59(12):7249-54. PubMed ID: 26369964
[TBL] [Abstract][Full Text] [Related]
16. Current Concepts and Future Directions in the Pharmacology and Treatment of Coccidioidomycosis.
Thompson GR; Lewis JS; Nix DE; Patterson TF
Med Mycol; 2019 Feb; 57(Supplement_1):S76-S84. PubMed ID: 30690601
[TBL] [Abstract][Full Text] [Related]
17. Efficacies of two novel azole derivatives each containing a morpholine ring, UR-9746 and UR-9751, against systemic murine coccidioidomycosis.
Clemons KV; Stevens DA
Antimicrob Agents Chemother; 1997 Jan; 41(1):200-3. PubMed ID: 8980782
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacies of terbinafine and fluconazole in treatment of experimental coccidioidal meningitis in a rabbit model.
Sorensen KN; Sobel RA; Clemons KV; Calderon L; Howell KJ; Irani PR; Pappagianis D; Williams PL; Stevens DA
Antimicrob Agents Chemother; 2000 Nov; 44(11):3087-91. PubMed ID: 11036027
[TBL] [Abstract][Full Text] [Related]
19. Efficacies of sordarin derivatives GM193663, GM211676, and GM237354 in a murine model of systemic coccidioidomycosis. p6.
Clemons KV; Stevens DA
Antimicrob Agents Chemother; 2000 Jul; 44(7):1874-7. PubMed ID: 10858347
[TBL] [Abstract][Full Text] [Related]
20. Direct in vitro comparison of the prodrug isavuconazonium sulfate with the isavuconazole active compound against Aspergillus spp. and 2 rare moulds.
Pfaller MA; Rhomberg PR; Castanheira M
Diagn Microbiol Infect Dis; 2018 Sep; 92(1):43-45. PubMed ID: 29735424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]